Author:
Ocampo Arnaldo F.,Biltoft Christel,Lucero Marilla,Ölander Rose-Marie,Ugpo Juanita,Auranen Kari,Soininen Anu,Nohynek Hanna,Käyhty Helena
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference31 articles.
1. Lucero M. Effectiveness of an 11-valent pneumococcal conjugate vaccine for preventing radiographically confirmed pneumonia in children under 2 years of age: a randomized, double-blind, placebo-controlled trial in the Philippines. In: 12th International Society for Infectious Diseases; 2006 June 15–18; Lisbon, Portugal; 2006.
2. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial;Cutts;Lancet,2005
3. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial;O’Brien;Lancet,2003
4. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection;Klugman;N Engl J Med,2003
5. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I;Hausdorff;Clin Infect Dis,2000